Physician profile
Sanjay Singh
NPI 1922072248
$46,081.34
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $8,524 · 2021: $1,795 · 2022: $25.85.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $39,946.35 | 2019-2021 | |
| Lilly USA, LLC | $2,200.00 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $711.99 | 2019-2020 | |
| Pfizer INC. | $578.46 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $422.60 | 2019-2021 | |
| Astellas Pharma US INC | $234.01 | 2019-2020 | |
| Amgen INC. | $232.94 | 2019-2020 | |
| Daiichi Sankyo INC. | $185.82 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $179.26 | 2019-2020 | |
| Gilead Sciences, INC. | $165.85 | 2019 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $132.67 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $122.19 | 2019-2020 | |
| Boston Scientific Corporation | $114.99 | 2019-2020 | |
| Philips North America LLC | $104.42 | 2020 | |
| Lundbeck LLC | $91.49 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $90.74 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $85.92 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $77.98 | 2019 | |
| Portola Pharmaceuticals, LLC | $73.49 | 2019 | |
| United Therapeutics Corporation | $58.47 | 2019-2020 | |
| Novo Nordisk INC | $51.24 | 2019 | |
| Bard Peripheral Vascular, INC. | $48.14 | 2019 | |
| Bardy Diagnostics, INC. | $30.47 | 2020 | |
| Terumo Medical Corporation | $25.85 | 2022 | |
| Abbott Laboratories | $23.28 | 2019 | |
| Angiodynamics, INC. | $20.20 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $20.16 | 2020 | |
| Biocompatibles, INC. | $18.11 | 2019 | |
| Braemar Manufacturing, LLC | $17.30 | 2019 | |
| Esperion Therapeutics, INC. | $16.95 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.